Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
16,228
Total Claims
$1.3M
Drug Cost
1,086
Beneficiaries
$1,170
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-17%
Cost per patient vs peers
$1,170 vs $1,411 avg
-11%
Brand preference vs peers
9.4% vs 10.6% avg
Brand vs Generic
Brand: 1,505 claims · $1.0M
Generic: 14,474 claims · $245K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 160 | $191K |
| Sitagliptin Phosphate | 59 | $88K |
| Semaglutide | 48 | $72K |
| Empagliflozin | 40 | $69K |
| Insulin Glargine,hum.Rec.Anlog | 50 | $41K |
| Canagliflozin | 23 | $37K |
| Rivaroxaban | 26 | $36K |
| Insulin Glargine,hum.Rec.Anlog | 38 | $34K |
| Tirzepatide | 23 | $32K |
| Sacubitril/Valsartan | 32 | $27K |
| Dulaglutide | 19 | $23K |
| Tiotropium Bromide | 21 | $22K |
| Insulin Nph Hum/Reg Insulin Hm | 32 | $21K |
| Dapagliflozin Propanediol | 14 | $18K |
| Fluticasone Propion/Salmeterol | 30 | $16K |
Prescribing Profile
Patient Profile
75
Avg Age
52%
Female
1.61
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data